Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues ...

Five years since it launched, advances powered by the National Drug Discovery Centre are helping transform medical research in Australia and fast-tracking development of new home-grown treatments.

The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancements in biotechnology and life sciences research.

A federal judge in Boston granted on Monday a temporary restraining order sought by Maine Attorney General Aaron Frey and ...